- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Phenylketonuria
- Meeting Date: July 2022
- Public Summary Document (PSD) July 2022 PBAC Meeting - (PDF 1MB)
- Public Summary Document (PSD) July 2022 PBAC Meeting - (Word 372KB)
Sapropterin – July 2022
Sapropterin: Tablet (soluble) containing sapropterin dihydrochloride 100 mg, Powder for oral solution 500 mg (as dihydrochloride); Kuvan®
Last updated
28 October 2022